ANIK compared with VRCA: revenue, margins and what each company keeps, and the suppliers and customers both name

ANIKAnika Therapeutics, Inc.

Mkt capRevenueRevenue

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

ANIKAnika Therapeutics, Inc.

VRCAVerrica Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ANIK 1

JNJJohnson & Johnson MedTechcustomer

Shared 0

No shared counterparties.

Only VRCA 1

—Lytix BioPharma ASunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

ANIKAnika Therapeutics, Inc.

19.26▼−0.80%

Mkt cap$259.8MRevenue$33MQ2 FY26Revenue$113MFY25

VRCAVerrica Pharmaceuticals Inc.

3.27▲+1.87%

Regular sessionNov 3 '26

Mkt cap$55.1MRevenue$6MQ2 FY26Revenue$36MFY25

Compare

Regular sessionNov 3 '26

ANIKAnika Therapeutics, Inc.

VRCAVerrica Pharmaceuticals Inc.

19.26▼−0.80%

Price

3.27▲+1.87%

$259.8M

Mkt cap

$55.1M

Q2 FY26$33M

Revenue

$6MQ2 FY26

FY25$113M

Revenue

$36MFY25

ANIK19.26▼−0.80%vsVRCA3.27▲+1.87%Regular sessionNov 3 '26